Disease | acne rosacea |
Symptom | C0041834|erythema |
Sentences | 8 |
PubMedID- 25505014 | Brimonidine gel (mirvaso-galderma) became available in february of this year for the symptomatic treatment of facial erythema associated with rosacea in adults.1 here, we review the evidence on brimonidine gel and consider its place in the management of erythema associated with rosacea. |
PubMedID- 25074756 | Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema. |
PubMedID- 24506775 | Methods: a pharmacokinetic study was conducted to compare intraindividual systemic exposures after dermal application of bt gel (0.07%, 0.18% and 0.5%) under maximal use conditions in patients with moderate-to-severe facial erythema associated with rosacea, and administration of bt ophthalmic solution 0.2%. |
PubMedID- 26022994 | Nearly 80% reported difficulty in controlling facial erythema but those with physician-diagnosed rosacea had significantly improved control versus those with undiagnosed rosacea (39% vs 20%, p < 0.05). |
PubMedID- 26099423 | Laser and light-based therapies for erythema in rosacea were effective (low-quality evidence). |
PubMedID- 23388530 | At the same time, a substantial reduction of erythema in patients with rosacea were not revealed. |
PubMedID- 25897253 | In two adults with refractory erythema and flushing associated with rosacea, oxymetazoline nasal solution 0.05% applied to facial skin demonstrated significant decreased erythema one hour after application that progressed to dramatic improvement within 3 hours and remained throughout the day25 (figure 6). |
PubMedID- 22768356 | erythema and flushing associated with rosacea remains an uncomfortable and socially embarrassing problem for patients. |
Page: 1